Evidence map›Paper›PMID 37312280›Full record

ArticleHealth expectations : an international journal of public participation in health care and health policy2023

Co-development of a school-based and primary care-based multicomponent intervention to improve HPV vaccine coverage amongst French adolescents (the PrevHPV Study).

Aurélie Bocquier, Sébastien Bruel, Morgane Michel, Anne-Sophie Le Duc-Banaszuk, Stéphanie Bonnay, Marion Branchereau, Karine Chevreul, Sandra Chyderiotis, Aurélie Gauchet, Bruno Giraudeau and 5 more

Open access · goldAbstract read
In one paragraph

Article in Health expectations : an international journal of public participation in health care and health policy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Co-development of a school-based and primary care-based multicomponent intervention to improve HPV vaccine coverage amongst French adolescents (the PrevHPV Study).Health expectations : an international journal of public participation in health care and health policy · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 8 institutions in 1 country.

Aurélie BocquierAPEMAC, Université de Lorraine, Nancy, France.ORCID 0000-0002-0192-8447
Sébastien BruelDepartment of General Practice, Jacques Lisfranc Faculty of Medicine, Saint-Etienne-Lyon University, Saint-Etienne, France.
Morgane MichelECEVE UMR 1123, Université de Paris Cité, Paris, France.
Anne-Sophie Le Duc-BanaszukCentre Régional de Coordination des Dépistages des cancers-Pays de la Loire, Angers, France.
Stéphanie BonnayAPEMAC, Université de Lorraine, Nancy, France.
Marion BranchereauCentre Régional de Coordination des Dépistages des cancers-Pays de la Loire, Angers, France.
Karine ChevreulECEVE UMR 1123, Université de Paris Cité, Paris, France.
Sandra ChyderiotisEmerging Disease Epidemiology Unit, Institut Pasteur, Université Paris Cité, Paris, France.
Aurélie GauchetLIP/PC2S, Université Grenoble Alpes, Grenoble, France.
Bruno GiraudeauSPHERE U1246, Université de Tours, Université de Nantes, INSERM, Tours, France.
Dragos-Paul HagiuDepartment of General Practice, Jacques Lisfranc Faculty of Medicine, Saint-Etienne-Lyon University, Saint-Etienne, France.
Judith E MuellerEmerging Disease Epidemiology Unit, Institut Pasteur, Université Paris Cité, Paris, France.
Amandine Gagneux-BrunonCentre International de Recherche en Infectiologie, Team GIMAP, Univ Lyon, Université Jean Monnet, Université Claude Bernard Lyon 1, Inserm, U1111, CNRS, UMR530, CIC INSERM 1408 Vaccinologie, CHU de Saint-Etienne, Saint-Etienne, France.
Nathalie ThillyAPEMAC, Université de Lorraine, Nancy, France.
PrevHPV Study Group
Interdisciplinarité en Santé Publique Interventions et Instruments de mesure complexes – Région Est · FRUniversité Claude Bernard Lyon 1 · FRUniversité Paris Cité · FRCentre National de la Recherche Scientifique · FRInserm · FRInstitut Pasteur · FRUniversité de Tours · FRUniversité Savoie Mont Blanc · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionDespite various efforts to improve human papillomavirus (HPV) vaccine coverage in France, it has always been lower than in most other high-income countries. The health authorities launched in 2018 the national PrevHPV research programme to (1) co-develop with stakeholders and (2) evaluate the impact of a multicomponent complex intervention aimed at improving HPV vaccine coverage amongst French adolescents.

objectiveTo describe the development process of the PrevHPV intervention using the GUIDance for rEporting of intervention Development framework as a guide.

methodsTo develop the intervention, we used findings from (1) published evidence on effective strategies to improve vaccination uptake and on theoretical frameworks of health behaviour change; (2) primary data on target populations' knowledge, beliefs, attitudes, preferences, behaviours and practices as well as the facilitators and barriers to HPV vaccination collected as part of the PrevHPV Programme and (3) the advice of working groups involving stakeholders in a participatory approach. We paid attention to developing an intervention that would maximise reach, adoption, implementation and maintenance in real-world contexts.

resultsWe co-developed three components: (1) adolescents' and parents' education and motivation using eHealth tools (web conferences, videos, and a serious video game) and participatory learning at school; (2) general practitioners' e-learning training on HPV using motivational interviewing techniques and provision of a decision aid tool and (3) easier access to vaccination through vaccination days organised on participating middle schools' premises to propose free of charge initiation of the HPV vaccination.

conclusionWe co-developed a multicomponent intervention that addresses a range of barriers and enablers of HPV vaccination. The next step is to build on the results of its evaluation to refine it before scaling it up if proven efficient. If so, it will add to the small number of multicomponent interventions aimed at improving HPV vaccination worldwide. PATIENT OR PUBLIC CONTRIBUTION: The public (adolescents, their parents, school staff and health professionals) participated in the needs assessment using a mixed methods approach. The public was also involved in the components' development process to generate ideas about potential activities/tools, critically revise the successive versions of the tools and provide advice about the intervention practicalities, feasibility and maintenance.

Indexed as

Papillomavirus InfectionsPapillomavirus VaccinesAdolescentHealth Knowledge, Attitudes, PracticeHumansParentsPatient Acceptance of Health CarePrimary Health CareVaccinationPapillomavirus Vaccinesco-constructioncomplex InterventioneHealth toolshuman papillomavirusmotivational interviewvaccination behaviours

Identifiers

PMID37312280
PMCPMC10485335
OpenAlexW4380442249

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.